(R) -Monlunabant
(R) -Monlunabant ((R) -MRI-1891) is a CB1 receptor mediators for research of obesity and metabolic disease[1]
Product Specifications
CAS Number
[2765579-76-6]
Product Name Alternative
(R) -MRI-1891; (R) -INV-202
UNSPSC
12352005
Target
Cannabinoid Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/r-monlunabant.html
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=S(N/C(N1N=C(C2=CC=C(C=C2)Cl)[C@H](C3=CC=CC=C3)C1)=N/C(NC(C)=O)=N)(C4=CC=C(C=C4)C(F)(F)F)=O
Molecular Formula
C26H22ClF3N6O3S
Molecular Weight
591.00
References & Citations
[1]George Kunos, et al. Cannabinoid receptor mediating compounds. Patent. US20180273485.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
sc-283352A 250 mg
2,3,4,6-Tetra-O-acetyl-1-deoxy-1-fluoro-a-D-galactopyranosyl cyanide
Ask
View Details 